Literature DB >> 11488662

Review article: should we kill or should we save Helicobacter pylori?

R H Hunt1, K Sumanac, J Q Huang.   

Abstract

Results from epidemiological studies and therapeutic clinical trials have shown that Helicobacter pylori infection causes acute and chronic active gastritis and is the initiating factor for the majority of peptic ulcer disease. Eradication of the infection with antibiotics resolves gastritis and restores normal gastric physiology, accelerates healing of peptic ulcer disease, and virtually eliminates recurrence of duodenal ulcer disease. The infection also plays an important role in the initiation and/or progression of gastric atrophy and intestinal metaplasia, which may eventually lead to the development of distal gastric cancer. Furthermore, almost all patients with gastric MALT lymphoma are infected with H. pylori and cure of the infection leads to histological regression of the tumor and maintains the regression in over 80% of patients during long-term follow-up. Preliminary uncontrolled data from Japan show that eradication of the infection significantly reduced metachronous intestinal-type gastric cancer following initial endoscopic resection of early gastric cancer and might also prevent the progression of gastric adenoma to gastric dysplasia or gastric cancer. Although this overwhelming evidence has demonstrated that H. pylori infection is bad for humans, some have questioned the wisdom of eradicating the infection in all those infected. Their arguments are largely based on hypothesis and circumstantial evidence: 1) Less than 20% of all H. pylori infected persons will develop significant clinical consequences in their lifetime. 2) H. pylori strains are highly diverse at a genetic level and are of different virulence. 3) The antiquity of H. pylori infection in humans and their co-evolution suggests that H. pylori may be a commensal to humans. Eradication of H. pylori may remove some beneficial bacterial strains and may provoke esophageal disease or gastric cancer at the cardia. However, careful review of the literature confirms that H. pylori infection is a serious pathogen albeit in a minority of those infected. It remains for carefully designed prospective studies, rather than hypothesis to make changes in the current consensus position.

Entities:  

Mesh:

Year:  2001        PMID: 11488662     DOI: 10.1046/j.1365-2036.2001.00107.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

2.  Helicobacter pylori infection and the onset of type 1 diabetes mellitus in Sudanese children.

Authors:  Samah M Osman; Samah M Mubarak; Ilham M Omer; Mohamed A Abdullah
Journal:  Sudan J Paediatr       Date:  2016

Review 3.  Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Authors:  Min-Min Zhang; Wei Qian; Ying-Yi Qin; Jia He; Yu-Hao Zhou
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.

Authors:  L M Best; D J M Haldane; M Keelan; D E Taylor; A B R Thomson; V Loo; C A Fallone; P Lyn; F M Smaill; R Hunt; C Gaudreau; J Kennedy; M Alfa; R Pelletier; S J O Veldhuyzen Van Zanten
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Effect of gastric acidification on the (14)C-UBT HELIPROBE(®) accuracy during Pantoprazole treatment in Helicobacter pylori positive patients.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammad Reza Sheykhian; Fatemeh Soati; Ali Mohammad Rafatzand
Journal:  Int J Clin Exp Med       Date:  2013-03-21

6.  Expression of Lewis(b) blood group antigen in Helicobacter pylori does not interfere with bacterial adhesion property.

Authors:  Peng-Yuan Zheng; Jiesong Hua; Han-Chung Ng; Khay-Guan Yeoh; Ho Bow
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

7.  Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran.

Authors:  Afshin Abdi-Rad; Siavash Ghaderi-sohi; Hosein Nadimi-Barfroosh; Sara Emami
Journal:  Diagn Pathol       Date:  2006-05-11       Impact factor: 2.644

8.  Prevalence of H. pylori among patients undergoing coronary angiography (The HP-DAPT prevalence study).

Authors:  Karel Huard; Kevin Haddad; Yacine Saada; John Nguyen; David Banon; Alexis Matteau; Samer Mansour; Brian J Potter
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.